Discover 1,743 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,743
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
for
HER2-negative Breast Cancer
Location: Ann Arbor MI, Detroit MI, Lansing MI, Flint MI,
Sponsor: NSABP Foundation Inc
Sex: Female
Age: 18+
Code: NCT03412643
Phase2, Recruiting
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
for
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Ypsilanti MI, Cleveland OH, Hinsdale IL, Hershey PA,
Sponsor: SynDevRx, Inc.
Sex: All
Age: 18+
Code: NCT05455619
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
for
Cardiovascular Diseases
Location: Ypsilanti MI, Asheville NC
Sponsor: Pritikin ICR
Sex: All
Age: 18+
Code: NCT06424119
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Ann Arbor MI, Canton MI, Chelsea MI, Livonia MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06770582
Phase2, Recruiting
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Ann Arbor MI, Goshen IN, Cincinnati OH, La Crosse WI,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT07211178
Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
for
Malignant Digestive System Neoplasm,
Location: Ann Arbor MI, Chelsea MI, Livonia MI, Pontiac MI,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT07215624
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Ann Arbor MI, Novi MI, West Bloomfield MI, Dearborn MI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT07200830
Phase3, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Ann Arbor MI, Detroit MI, Columbus OH, Chicago IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase3, Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
for
Atrial Fibrillation
Location: Ypsilanti MI, Springfield OH, Cincinnati OH,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 22+
Code: NCT07227532
Recruiting
BoxX-NoAF Clinical Trial
for
Post Operative Atrial Fibrillation,
Location: Ypsilanti MI, Grand Rapids MI, Cleveland OH, London,
Sponsor: AtriCure, Inc.
Sex: All
Age: 65+
Code: NCT06989775
Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Ann Arbor MI, Novi MI, West Bloomfield MI, Dearborn MI,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase3, Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for
Acute Decompensated Heart Failure
Location: Ann Arbor MI, Royal Oak MI, Grand Rapids MI,
Sponsor: Reprieve Cardiovascular, Inc
Sex: All
Age: 22+
Code: NCT06898515
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Ann Arbor MI, Indianapolis IN, Chicago IL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase3, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Ann Arbor MI, Grand Rapids MI, Centerville OH,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Ypsilanti MI, Peoria IL, York PA, Washington DC DC,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer